Min-Hua Chen

Prof. Min-Hua Chen

Chung Yuan Christian University
+1
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Acta Biomaterialia
Verified
Journal Article
Closed access
Min-Hua ChenMin-Hua Chen
Min-Hua Chen
NHNobutaka Hanagata
Nobutaka Hanagata
TIToshiyuki Ikoma
Toshiyuki Ikoma
JHJian-Yuan Huang
Jian-Yuan Huang
KLKeng-Yuan Li
Keng-Yuan Li
Feng-Huei LinFeng-Huei Lin
Feng-Huei Lin

21 January 2017 in Discover Nano
Verified
Journal Article
Open access
PDF file
Min-Hua ChenMin-Hua Chen
Min-Hua Chen
YJYi-Jhen Jenh
Yi-Jhen Jenh
SWSheng-Kai Wu
Sheng-Kai Wu
YCYo-Shen Chen
Yo-Shen Chen
AHand Nobutaka Hanagata
and Nobutaka Hanagata
Feng-Huei LinFeng-Huei Lin
Feng-Huei Lin
The use of photodynamic therapy (PDT) in the treatment of brain cancer has produced exciting results in clinical trials over the past decade. PDT is based on the concept that a photosensitizer exposed to a specific light wavelength produces the predominant cytotoxic agent, to destroy tumor cells. However, delivering an efficient light source to the brain tumor site is still a challenge. The light source should be delivered by placing external optical fibers into the brain at the time of surgical debulking of the tumor. Consequently, there exists the need for a minimally invasive treatment for brain cancer PDT. In this study, we investigated an attractive non-invasive option on glioma cell line by using Tb3+-doped LaF3 scintillating nanoparticles (LaF3:Tb) in combination with photosensitizer, meso-tetra(4-carboxyphenyl)porphyrin (MTCP), followed by activation with soft X-ray (80 kVp). Scintillating LaF3:Tb nanoparticles, with sizes of approximately 25 nm, were fabricated. The particles have a good dispersibility in aqueous solution and possess high biocompatibility. However, significant cytotoxicity was observed in the glioma cells while the LaF3:Tb nanoparticles with MTCP were exposed under X-ray irradiation. The study has demonstrated a proof of concept as a non-invasive way to treat brain cancer in the future.

1 January 2010 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
YCYa-Jen Chang
Ya-Jen Chang
CCChih-Hsien Chang
Chih-Hsien Chang
CYChia-Yu Yu
Chia-Yu Yu
TCTsui-Jung Chang
Tsui-Jung Chang
LCLiang-Cheng Chen
Liang-Cheng Chen
GTGann Ting
Gann Ting

1 October 2014 in Science and Technology of Advanced Materials
Verified
Journal Article
Open access
Min-Hua ChenMin-Hua Chen
Min-Hua Chen
TYTomohiko Yoshioka
Tomohiko Yoshioka
TIToshiyuki Ikoma
Toshiyuki Ikoma
NHNobutaka Hanagata
Nobutaka Hanagata
Feng-Huei LinFeng-Huei Lin
Feng-Huei Lin
JTJunzo Tanaka
Junzo Tanaka
Theranostic nanoparticles currently have been regarded as an emerging concept of ‘personalized medicine’ with diagnostic and therapeutic dual-functions. Eu3+ doped hydroxyapatite (HAp) has been regarded as a promising fluorescent probe for in vivo imaging applications. Additionally, substitution of Ca2+ with Fe3+ in HAp crystal may endow the capability of producing heat upon exposure to a magnetic field. Here we report a preliminary study of doping mechanism and photoluminescence of Eu3+ and Fe3+ doped HAp nanoparticles (Eu/Fe:HAp). HAp with varied concentration of Eu3+ and Fe3+ doping are presented as Eu(10 mol%):HAp, Eu(7 mol%)-Fe(3 mol%):HAp, Eu(5 mol%)-Fe(5 mol%):HAp, Eu(3 mol%)-Fe(7 mol%):HAp, and Fe(10 mol%):HAp in the study. The results showed that the HAp particles, in nano-size with rod-like morphology, were successfully doped with Eu3+ and Fe3+, and the particles can be well suspended in cell culture medium. Photoluminescence analysis revealed that particles have prominent emissions at 5...

1 March 2015 in Ceramics International
Verified
Journal Article
Closed access
JHJian-Yuan Huang
Jian-Yuan Huang
Min-Hua ChenMin-Hua Chen
Min-Hua Chen
WKWei-Ting Kuo
Wei-Ting Kuo
YSYu-Jun Sun
Yu-Jun Sun
FLFeng-Huei Lin
Feng-Huei Lin

1 May 2011 in Biomaterials
Verified
Journal Article
Closed access
LTLin-Ren Tsai
Lin-Ren Tsai
Min-Hua ChenMin-Hua Chen
Min-Hua Chen
CCChih-Te Chien
Chih-Te Chien
MCMeng-Kai Chen
Meng-Kai Chen
FLFong-Sian Lin
Fong-Sian Lin
SLShu-Yi Lin
Shu-Yi Lin